Nektar Therapeutics (NASDAQ:NKTR)

5.14
Delayed Data
As of Aug 12
 +0.19 / +3.84%
Today’s Change
3.02
Today|||52-Week Range
19.37
-61.95%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Greer R Scott
Director
Buy8/31/202145,000$12.70$571.5K-66.80%
Robin Howard W
President & Chief Executive Officer
Sale11/16/202142,773$13.16$562.9K-61.32%
Whitfield Roy A
Director
Buy9/16/202140,000$13.80$552.0K-68.39%
Labrucherie Gilbert M
Chief Operating & Financial Officer & Senior VP
Sale11/16/202121,149$13.16$278.3K-61.32%
Zalevsky Jonathan
Chief Research & Development Officer
Sale11/16/202120,869$13.16$274.6K-61.32%
Thomsen Jillian B
Chief Accounting Officer & Senior Vice President
Sale8/16/202113,339$13.83$184.5K-62.67%
Chess Robert B
Director
Sale9/09/202110,279$16.02$164.7K-67.43%
Greer R Scott
Director
Buy11/09/202112,500$12.80$160.0K-62.81%
Robin Howard W
President & Chief Executive Officer
Sale8/16/202111,515$13.83$159.3K-62.67%
Robin Howard W
President & Chief Executive Officer
Sale5/16/202236,529$3.95$144.3K+32.47%
Page of 7